US Patent 11180732 Amniotic fluid cell-derived extracellular matrix and uses thereof

Patent 11180732 was granted and assigned to Stembiosys, Inc. on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111807320

Patent Inventor Names

Travis Block0

Edward S. Griffey0

Mary Navarro0

Date of Patent

November 23, 2021

Patent Application Number

165925390

Date Filed

October 3, 2019

Patent Primary Examiner

‌

Teresa E Knight

Patent abstract

Disclosed is a cell-derived extracellular matrix (ECM) derived in vitro from cells isolated from amniotic fluid, and methods of use for the isolation, maintenance, and proliferation of adherent cells including stem cells, as well as for the differentiation of stem cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11180732 Amniotic fluid cell-derived extracellular matrix and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API